Parenteral versus oral antibiotic therapy

Area of Science:

• Infectious Diseases
• Pharmacology
• Clinical Medicine

Background:

• The last decade has seen a significant shift towards oral therapy for serious infections previously requiring parenteral administration.
• Advances in antimicrobial agents have expanded the utility of oral medications.

Purpose of the Study:

• To evaluate the efficacy of new oral antimicrobial agents compared to traditional parenteral therapy for serious infections.
• To highlight the pharmacokinetic advantages and cost-effectiveness of oral treatment options.

Main Methods:

• Review of clinical trials comparing oral and parenteral therapies for pneumonia, urinary tract infections, skin and soft tissue infections, osteomyelitis, and bacteremia.
• Analysis of pharmacokinetic data, including AUC/MIC ratios for fluoroquinolones and levels above MIC for cephalosporins and beta-lactams.

Main Results:

• Clinical trials demonstrate equal efficacy between oral and parenteral therapies for various serious infections.
• New oral agents, including fluoroquinolones and cephalosporins, exhibit enhanced activity against gram-negative bacilli and improved pharmacokinetics.
• Achieving therapeutic serum levels (e.g., 24-hour AUC/MIC > 125 for fluoroquinolones) is possible with oral administration.

Conclusions:

• Oral therapy is a viable and effective alternative to parenteral therapy for numerous serious infections.
• Improved oral antimicrobial agents offer comparable efficacy, better pharmacokinetics, and reduced treatment costs.
• The findings support the expanded use of oral antibiotics in clinical practice for managing serious infections.